| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1998;116:460-464
© 1998 Mosby, Inc.
Surgery for Adult Cardiovascular Disease |
The Institutions of the Multicenter Study of Perioperative Ischemia(McSPI) Research Group
See Appendixes 1 and 2 for list of McSPIinvestigators and central analysis group members.
Objectives: No data exist regarding"the best" hematocrit value after coronary artery bypass graftsurgery. Transfusion practice varies, because neither an optimal hematocritvalue nor a uniform transfusion trigger criterion has been determined.
Methods: To investigate the optimal hematocrit value, westudied 2202 patients undergoing coronary bypass. The hematocrit value on entryinto the intensive care unit (IHCT) was categorized into three groups: high (
34%),medium (25% to 33%), and low (24%). Characteristics andadverse events (outcomes) were compared, and the effect of IHCT on the risk ofmyocardial infarction was determined by logistic regression.
Results: High IHCT (34%) was associated with anincreased rate of myocardial infarction (8.3% vs 5.5% vs 3.6%;P 0.03, high, medium vs low) and with moresevere left ventricular dysfunction (11.7% vs 7.4% and 5.7%;P = 0.006, high, medium vs low). Mortalityrate increased with higher IHCT when all the high-risk subgroups were combined(8.6% vs 4.5% vs 3.2%; P <0.001, high, medium vs low). By multivariate analysis, IHCT remained the mostsignificant predictor of adverse outcomes (relative risk high vs low 2.22, 95%confidence interval: 1.04 to 4.76). No characteristic, event, medication, ortransfusion therapy confounded the relationship between IHCT and outcome.
Conclusion: High IHCT is associated with a higher rate ofmyocardial infarction and is an independent predictor of infarction. On thebasis of the risk of myocardial infarction, there is no rationale fortransfusion to an arbitrary level after coronary artery bypass grafting. (JThorac Cardiovasc Surg 1998;116:460-7)
This article has been cited by other articles:
|
|
 |
|
  F. Capuano, C. Simon, A. Roscitano, G. Sclafani, E. Tonelli, and R. Sinatra Cardiac Troponin I Concentrations During On-Pump Coronary Artery Surgery Asian Cardiovasc Thorac Ann, December 1, 2007; 15(6): 502 - 506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kulier, J. Levin, R. Moser, G. Rumpold-Seitlinger, I. C. Tudor, S. A. Snyder-Ramos, P. Moehnle, D. T. Mangano, and for the Investigators of the Multicenter Study of Impact of Preoperative Anemia on Outcome in Patients Undergoing Coronary Artery Bypass Graft Surgery Circulation, July 31, 2007; 116(5): 471 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Murphy and G. D. Angelini Indications for Blood Transfusion in Cardiac Surgery Ann. Thorac. Surg., December 1, 2006; 82(6): 2323 - 2334. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G.J. Murphy, C.S. Rogers, W.B. Lansdowne, I. Channon, H. Alwair, A. Cohen, M. Caputo, and G.D. Angelini Safety, efficacy, and cost of intraoperative cell salvage and autotransfusion after off-pump coronary artery bypass surgery: A randomized trial J. Thorac. Cardiovasc. Surg., July 1, 2005; 130(1): 20 - 28. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Madjdpour and D. R. Spahn Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications Br. J. Anaesth., July 1, 2005; 95(1): 33 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. O. Cheng Is There an Optimal Hematocrit Value for Cardiac Patients? J. Am. Coll. Cardiol., May 3, 2005; 45(9): 1549 - 1549. [Full Text]
|
|
|
|
|
|
J. H. Shuhaiber Randomized prospective trial for blood transfusion during adult cardiopulmonary bypass surgery J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 1200 - 1201. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kuduvalli, A. Y. Oo, N. Newall, A. D. Grayson, M. Jackson, M. J. Desmond, B. M. Fabri, and A. Rashid Effect of peri-operative red blood cell transfusion on 30-day and 1-year mortality following coronary artery bypass surgery Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 592 - 598. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Spiess Transfusion of Blood Products Affects Outcome in Cardiac Surgery Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2004; 8(4): 267 - 281. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Couvret, M. Laffon, A. Baud, V. Payen, P. Burdin, and J. Fusciardi A Restrictive Use of Both Autologous Donation and Recombinant Human Erythropoietin Is an Efficient Policy for Primary Total Hip or Knee Arthroplasty Anesth. Analg., July 1, 2004; 99(1): 262 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Engoren, C. Arslanian-Engoren, and N. Fenn-Buderer Hospital and Long-term Outcome After Tracheostomy for Respiratory Failure Chest, January 1, 2004; 125(1): 220 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. T. Mangano and the Multicenter Study of Perioperative Ischemia Re Aspirin and Mortality from Coronary Bypass Surgery N. Engl. J. Med., October 24, 2002; 347(17): 1309 - 1317. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Speiss Transfusion and outcome in heart surgery Ann. Thorac. Surg., October 1, 2002; 74(4): 986 - 987. [Full Text] [PDF]
|
|
|
|
|
|
M. C. Engoren, R. H. Habib, A. Zacharias, T. A. Schwann, C. J. Riordan, and S. J. Durham Effect of blood transfusion on long-term survival after cardiac operation Ann. Thorac. Surg., October 1, 2002; 74(4): 1180 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Balachandran, M. H. Cross, S. Karthikeyan, A. Mulpur, S. D. Hansbro, and P. Hobson Retrograde autologous priming of the cardiopulmonary bypass circuit reduces blood transfusion after coronary artery surgery Ann. Thorac. Surg., June 1, 2002; 73(6): 1912 - 1918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. McGill, D. O'Shaughnessy, R. Pickering, M. Herbertson, and R. Gill Mechanical methods of reducing blood transfusion in cardiac surgery: randomised controlled trial BMJ, June 1, 2002; 324(7349): 1299 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Couvret, S. Tricoche, A. Baud, B. Dabo, S. Buchet, M. Palud, and J. Fusciardi The Reduction of Preoperative Autologous Blood Donation for Primary Total Hip or Knee Arthroplasty: The Effect on Subsequent Transfusion Rates Anesth. Analg., April 1, 2002; 94(4): 815 - 823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Albert, S. Perelman, D. Moskowitz, H. Bennett, J.-F. Hardy, S. S. Rathore, W.-C. Wu, H. M. Krumholz, R. G. Bach, and L. T. Goodnough Transfusion in Elderly Patients with Myocardial Infarction N. Engl. J. Med., March 7, 2002; 346(10): 779 - 782. [Full Text] [PDF]
|
|
|
|
 |
|
 R. C Groom High or low hematocrits during cardiopulmonary bypass for patients undergoing coronary artery bypass graft surgery? An evidence-based approach to the question Perfusion, March 1, 2002; 17(2): 99 - 102. [PDF]
|
|
|
|
|
|
G. A. Nuttall, J. A. Garrity, J. A. Dearani, M. D. Abel, D. R. Schroeder, and C. J. Mullany Risk Factors for Ischemic Optic Neuropathy After Cardiopulmonary Bypass: A Matched Case/Control Study Anesth. Analg., December 1, 2001; 93(6): 1410 - 1416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Spiess Blood transfusion: the silent epidemic Ann. Thorac. Surg., November 1, 2001; 72(5): S1832 - 1837. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Van der Linden, S. De Hert, A. Daper, A. Trenchant, D. Jacobs, C. De Boelpaepe, P. Kimbimbi, P. Defrance, and G. Simoens A standardized multidisciplinary approach reduces the use of allogeneic blood products in patients undergoing cardiac surgery : [L'approche systematique et multidisciplinaire diminue le recours aux produits sanguins allogenes chez les malades operes du coeur] Can J Anesth, October 1, 2001; 48(9): 894 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C Groom High or low hematocrits during cardiopulmonary bypass for patients undergoing coronary artery bypass graft surgery? An evidence-based approach to the question Perfusion, September 1, 2001; 16(5): 339 - 343. [PDF]
|
|
|
|
|
|
M H Cross Autotransfusion in cardiac surgery Perfusion, September 1, 2001; 16(5): 391 - 400. [Abstract] [PDF]
|
|
|
|
|
|
J.-F. Hardy and S. Belisle Erythrocyte transfusion: friend or foe? Can J Anesth, June 1, 2001; 48(90001): R10 - 10. [Full Text] [PDF]
|
|
|
|
|
|
M. F. O'Connor and J. L. Apfelbaum Update on Transfusion Therapy Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2000; 4(4): 236 - 243. [Abstract] [PDF]
|
|
|
|
|
|
J. E Cormack, R. J Forest, R. C Groom, and J. Morton Size makes a difference: use of a low-prime cardiopulmonary bypass circuit and autologous priming in small adults Perfusion, March 1, 2000; 15(2): 129 - 135. [Abstract] [PDF]
|
|
|
|
|
|
A. M.-H. Ho, D. C. Chung, and G. M. Joynt Neuraxial Blockade and Hematoma in Cardiac Surgery: Estimating the Risk of a Rare Adverse Event That Has Not (Yet) Occurred Chest, February 1, 2000; 117(2): 551 - 555. [Full Text] [PDF]
|
|
|
|
|
|
E.-S. Tan, J. van der Meer, P. Jan de Kam, P. H. J. M. Dunselman, B. J. M. Mulder, C. A. P. L. Ascoop, M. Pfisterer, K. I. Lie, and for CABADAS Research Group of the Interuniversity Worse clinical outcome but similar graft patency in women versus men one year after coronary artery bypass graft surgery owing to an excess of exposed risk factors in women J. Am. Coll. Cardiol., November 15, 1999; 34(6): 1760 - 1768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Graham and H. O’Kane Is a high hematocrit value an independent risk factor for adverse outcome after coronary artery bypass grafting? J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 765 - 765. [Full Text]
|
|
|
|
|
|
L. T. Goodnough, M. E. Brecher, M. H. Kanter, and J. P. AuBuchon Transfusion Medicine -- Blood Transfusion- First of Two Parts N. Engl. J. Med., February 11, 1999; 340(6): 438 - 447. [Full Text] [PDF]
|
|
|
|
|
|
T. O. Cheng High hematocrit value is a risk factor for myocardial infarction J. Thorac. Cardiovasc. Surg., January 1, 1999; 117(1): 199 - 200. [Full Text]
|
|
|
|
 |
|
 Postoperative Anemia -- Not Harmful After CABG Journal Watch Cardiology, October 16, 1998; 1998(1016): 4 - 4. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
